NFE2L2 and Patent ductus arteriosus: nuclear factor erythroid 2–related factor 2 (NRF2), a master regulator of oxidative stress responses (16–18), is frequently upregulated in PDA, in which it promotes tumor growth and chemoresistance (14, 15).